Ranibizumab ophthalmic and Sofosbuvir and velpatasvir
Determining the interaction of Ranibizumab ophthalmic and Sofosbuvir and velpatasvir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: sofosbuvir / velpatasvir
Brand name: Epclusa
Synonyms: Sofosbuvir and Velpatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Sofosbuvir Tablets
- Ranibizumab ophthalmic-Sofosbuvir, velpatasvir, and voxilaprevir
- Ranibizumab ophthalmic-Sojourn
- Ranibizumab ophthalmic-Sojourn Inhalant
- Ranibizumab ophthalmic-Solage
- Ranibizumab ophthalmic-Solage Topical
- Sofosbuvir and velpatasvir-Ranitidine
- Sofosbuvir and velpatasvir-Ranitidine Capsule
- Sofosbuvir and velpatasvir-Ranitidine Hydrochloride
- Sofosbuvir and velpatasvir-Ranitidine Injection
- Sofosbuvir and velpatasvir-Ranitidine Suspension
- Sofosbuvir and velpatasvir-Ranitidine Syrup